|
| |
| | | 67781 | | 15.02.2021 | | Teva Pharma AG | | | | | | | 14.02.2026 | | | | | | 07.16.10. | | | | 07.16.10. | | IP |
| | Seq.-No. | Product | Description | Galenic form | ATC-classification | |
|---|
| 01 | Sunitinib-Teva 12.5 mg | Hartkapseln | Capsules (Sunitinib 12.5 mg) | L01EX01 | CI | | 02 | Sunitinib-Teva 25 mg | Hartkapseln | Capsules (Sunitinib 25 mg) | L01EX01 | | | 03 | Sunitinib-Teva 37.5 mg | Hartkapseln | Capsules (Sunitinib 37.5 mg) | L01XE04 | | | 04 | Sunitinib-Teva 50 mg | Hartkapseln | Capsules (Sunitinib 50 mg) | L01EX01 | |
|
|
|
